Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „haemophilia“
Suchtreffer
Begriffe & Kennungen
Advate · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenAdvate · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenAdynovi · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenAdynovi · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenAdynovi · 4.8 · The safety of ADYNOVI was evaluated in 478 unique patients with severe haemophilia A (factor VIII less than 1%
Eintrag öffnenAdynovi · 4.8 · The safety of ADYNOVI was evaluated in 478 unique patients with severe haemophilia A (factor VIII less than 1%
Eintrag öffnenAfstyla · 4.8 · Development of neutralizing antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenAlprolix · 4.8 · Patients with haemophilia B may develop neutralising antibodies (inhibitors) to factor IX. If such inhibitors
Eintrag öffnenAlprolix · 4.8 · Previously Untreated Patients (PUPs): A total of 33 patients with severe haemophilia B were observed in one cl
Eintrag öffnenAltuvoct · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenBeneFIX · 4.8 · Patients with haemophilia B may develop neutralising antibodies (inhibitors) to factor IX. If such inhibitors
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Bleeding in haemophiliac patients There have been reports of increased spontaneous bleeding in haemophiliac pa
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Bleeding in haemophiliac patients There have been reports of increased spontaneous bleeding in haemophiliac pa
Eintrag öffnenElocta · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenEsperoct · 4.8 · 7 an insufficient clinical response. In such cases, it is recommended that a specialised haemophilia centre is
Eintrag öffnenEsperoct · 4.8 · Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia A treated with fact
Eintrag öffnenHämophilie A
Eintrag öffnenHämophilie B
Eintrag öffnenIdelvion · 4.8 · Patients with haemophilia B may develop neutralising antibodies (inhibitors) to factor IX. If such inhibitors
Eintrag öffnenJivi · 4.8 · 9 severe haemophilia A (FVIII:C < 1%), and ≥ 150 previous exposure days and 108 paediatric PTPs < 12 years of
Eintrag öffnen